This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Sweet Superfood: Health Benefits of Dates for Women Over 40 Dates, often called "nature's candy," have been enjoyed for centuries as a delicious and nutrient-packed fruit. For women over 40, dates are an excellent way to boost energy, support digestive health, and promote overall well-being. Packed with essential vitamins, minerals, and fibre, they’re a simple addition to your diet that can make a big impact on your health.
Is silica in skincare safe? Word on the beauty streets is that silica is trying to kill you. Silica is the latest ingredient accused of giving you silicosis and all sorts of nasty diseases. Once the rumours start, everyone adds its fair share of gossip and side effects. We don’t do gossip here. We do […] The post Is Silica in Skincare Dangerous?
The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorization in Great Britain for delgocitinib cream (Anzupgo, Leo Pharma) for the treatment of adult patients with moderate to severe chronic hand eczema (CHE), for whom topical corticosteroids are inadequate or inappropriate. Delgocitinib cream is now the first approved topical pan-Janus kinase (JAK) inhibitor treatment specifically for adults with moderate to severe CHE in Great Britain.
LOV has unique clinical traits, epidemiology, and treatment responses compared to early-onset vitiligo, underscoring the need for a tailored management approach.
When did we begin to fear aging? Journey with us, as we explore beauty's obsession with beating father time and explore how this conversation is starting to change.
When did we begin to fear aging? Journey with us, as we explore beauty's obsession with beating father time and explore how this conversation is starting to change.
Johnson & Johnson submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) seeking approval of guselkumab (Tremfya) for the treatment of children 6 and older with moderate-to-severe plaque psoriasis (PsO) and children 5 and up with active juvenile psoriatic arthritis (jPsA). Guselkumab is the first approved monoclonal antibody that selectively binds to the p19 subunit of interleukin (IL)-23 and inhibits its interaction with the IL-23 re
Treatment with delgocitinib led to a significant decrease in the expression of inflammatory markers that were elevated in severe cases compared with mild cases at baseline.
Panelists discuss how atopic dermatitis impacts different demographic groups through variations in disease presentation, treatment access, and quality of life outcomes.
Panelists discuss how atopic dermatitis significantly impacts patients' mental health, social relationships, and daily activities, creating substantial psychosocial burdens that can lead to anxiety, depression, and reduced quality of life.
Panelists discuss how health care providers must balance the convenience and accessibility of telemedicine with individual patient needs and clinical considerations when delivering dermatological care.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
102 
Let's personalize your content